← Back to Search

Impedance Cardiography for High Blood Pressure

N/A
Waitlist Available
Led By Anthony Viera, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1.5 months
Awards & highlights

Study Summary

The purpose of this research study is to use a test called impedance cardiography (ICG) to provide more information about how to improve the control of blood pressure. Participants will be given this test so investigators can get more information about what is going on inside the heart and blood vessels that is contributing to high blood pressure. ICG is a lot like an EKG (electrocardiogram) in that it uses electrodes and a computer to make a report. Participants will lie down on the exam table and two electrodes go on the right ankle and two electrodes go on the left wrist. The process takes about 5 minutes and is painless and not invasive.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1.5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1.5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants Enrolled as Measured by Enrollment Logs
Number of Participants That Completed Study as Measured by Enrollment Logs
Secondary outcome measures
Change in Blood Pressure as Measured by Medical Record
Number of Anti-hypertensive Medications Prescribed as Measured by Medical Record Review

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hypertension patientsExperimental Treatment2 Interventions
Patients with documented diagnosis of hypertension and their most recent office systolic BP average measured using automated office BP is ≥140 mmHg systolic or ≥90 mmHg diastolic and they are currently prescribed at least one BP-lowering medication will be recruited.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hypertension medication algorithm
2022
N/A
~20
Impedance Cardiography
2022
N/A
~110

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,363 Previous Clinical Trials
3,420,466 Total Patients Enrolled
Anthony Viera, MDPrincipal InvestigatorDuke University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Tailored to You (TTY) Pilot Study
2022. "Tailored to You (TTY) Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05141175.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top